2bind–Dynamic Biosensors: switchSENSE technology, 202209– collab technology-service with 2bind using HeliX biosensor system as certified beta customer |
2022-09-01 |
908 Devices–ARCH Venture: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor ARCH Ventures |
2019-04-29 |
908 Devices–Casdin Capital: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Casdin Capital |
2019-04-29 |
908 Devices–Manufacturing USA: grant, 201907– grant from NIIMBL for developm of at-line bioreactor process analytics tog w MilliporeSigma et al |
2019-07-25 |
908 Devices–Northpond Ventures: investment, 201904 financing round Series E totalling $17.5m incl new + lead investor Northpond Ventures |
2019-04-29 |
908 Devices–Razor’s Edge Ventures: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Razor’s Edge Ventures |
2019-04-29 |
908 Devices–Sands Capital: investment, 201904 financing round Series E totalling $17.5m incl new + co-investor Sands Capital Ventures |
2019-04-29 |
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool |
2021-06-22 |
908 Devices–Saudi Arabia: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Saudi Aramco Energy Ventures |
2019-04-29 |
908 Devices–Schlumberger: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Schlumberger |
2019-04-29 |
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS |
2021-06-22 |
908 Devices–SEVERAL: investment, 201904 financing round Series E $17.5m led by new investor Northpond Ventures |
2019-04-29 |
908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m net $136.6m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market |
2020-12-18 |
908 Devices–SEVERAL: investment, 202111 public offering $100.8m net $94.4m with 3.15m shares common stock at $32/share |
2021-11-15 |
908 Devices–Tao Capital: investment, 201904 financing round Series E totalling $17.5m incl existing + co-investor Tao Capital Partners |
2019-04-29 |
Abcam–Danaher: investment, 202308– acquisition $24/share in cash = enterprise value $5.7b incl assumed indebtedness + net of acquired cash |
2023-08-28 |
Accenture–PerkinElmer: bioinformatics, 201904– collab product integration of PE informatics solutions into Accenture Life Sciences platform |
2019-04-16 |
Acquifer Imaging–Bruker: investment, 202301 acquisition €na of Acquifer Imaging Gmbh + subsidiary Deltabyte GmbH by Bruker |
2023-01-05 |
Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp |
2021-01-06 |
Adeptrix–SEVERAL: investment, 202101 financing round Series A closed with new + minority investor Bruker Corp |
2021-01-06 |
Agena Bioscience–Mesa Labs: investment, 202109– acquisition $300m in cash of Agena by Mesa Laboratories ANNOUNCED |
2021-09-14 |
Agendia–Inivata: cancer test, 202104– co-excl distribution rights €na for RaDaR liquid biopsy assay for breast cancer in North America + Europe |
2021-04-28 |
Agilent–Akoya Biosciences: IHC diagnostics, 202301– collab developm + marketing solutions integrating Dako Omnis instrument + PhenoImager HT system |
|
Agilent–e-MSion: mass spectrometry technology, 2019– collab co-marketing of ExD cell technology with 6500 Series LC-/Q-TOF |
2023-03-09 |
Agilent–Exact Sciences: investment, 202309– acquisition €na of Resolution Bioscience by Exact Sciences from Agilent |
2023-09-12 |
Agilent–Frost & Sullivan: market research, 201906 supply service survey of pharma lab leaders on lab workflows by F&S |
2019-06-04 |
Agilent–Hamamatsu: digital pathology, 202303– collab distribution of NanoZoomer digital pathology slide scanners by Agilent |
2023-03-10 |
Agilent–Mettler-Toledo: lab automation, –202206 collab developm + product integration automated + digitalised sample prep for LC/GC workflow |
2022-06-01 |
Agilent–Mobilion: mass spectrometry, 2018– collab integration of SLIM ion mobility technology with Agilent Q-TOF MS platform |
2018-01-01 |
Agilent–Plasmion: ionisation technology, 202301– collab co-marketing of SICRIT ion source with Agilent Ultivo LC/TQ + LC/MSD iQ MS systems |
2023-01-18 |
Agilent–Proscia: digital pathology, 202303– collab ww distribution multi-year for Concentriq Dx platform with Agilent digital pathology solutions |
2023-03-08 |
Agilent–Scitara: lab informatics, 202209– collab product integration of OpenLab CDS + SLIMS with Scientific Integration Platform SIP + DLX |
2022-09-21 |
Agilent–SEVERAL: credit, 201909–202909 public offering $500m net $492.8m Senior Notes 2.75% due Sept 2029 |
2019-09-05 |
Agilent–Sigsense Technologies: lab management software, 202407 supply existent Sigsense technology available via Agilent CrossLab Connect |
2024-07-29 |
Agilent–Visiopharm: image analysis software, 202003– collab co-marketing of Visiopharm’s AI-driven solutions for digital pathology |
2020-03-02 |
Akribion–Bruker: investment, 202502 seed financing round totalling €8m incl co-investor Bruker Invest |
2025-02-04 |
Akribion–High-Tech Gründerfonds: investment, 202502 seed financing round totalling €8m incl co-investor HTGF |
2025-02-04 |
Akribion–Optimum Strategic Communications: public relations, 202502 service existent by Optimum |
2025-02-04 |
Akribion–SEVERAL: investment, 202502 seed financing round €8m led by Carma Fund + RV Invest |
2025-02-04 |
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED |
2021-06-17 |
Alphalytik Pharmaservice–Certania: investment, 202409 acquisition of Alphalytik Pharmaservice GmbH by Certania |
2024-09-04 |
Andrew Alliance–Waters: investment, 202001 acquisition by existent investor Waters |
2020-01-13 |
Arxspan–Bruker: investment, 201903 acquisition €na of Arxspan LLC by Bruker |
2019-03-14 |
Aston Univ–Waters: mass spectrometer, 201911 supply first Select Series Cyclic IMS mass spectrometer installed at School of Health + Life Sciences |
2019-11-07 |
Astrea Bioseparations–Biotage: investment, 202302– acquisition $190m in shares + $45 cash milestones of Astrea from Gamma Biosciences (KKR) |
2023-02-15 |
Atavistik Bio–Column Group: investment, 202108 financing round Series A totalling $60m incl lead investor The Columm Group |
2021-08-24 |
Atavistik Bio–Lux Capital: investment, 202108 financing round Series A totalling $60m incl co-investor Lux Capital |
2021-08-24 |
Atavistik Bio–Nextech: investment, 202108 financing round Series A totalling $60m incl co-investor Nextech Invest Ltd |
2021-08-24 |
Atavistik Bio–SEVERAL: investment, 202108 financing round Series A $60m led by The Columm Group with Lux Capital + Nextech Invest |
2021-08-24 |
Atlas Antibodies–Genovis: MS-based analysis of biopharmaceuticals, 202208– supply service LC-MS analytics of recombinant CHO-antibodies to Evitria |
2022-08-08 |
Atonarp–SEVERAL: investment, 201908 financing round Series C $33m |
2019-08-26 |
Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD |
2021-01-28 |
Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test |
2021-01-28 |
Axel Semrau–Trajan: investment, 202111 acquisition €19.85m by Trajan Group |
2021-11-18 |
BIA Separations–Sartorius: investment, 202010– acquisition €240m in cash + €120m in SSB shares BIA to be merged into SSB ANNOUNCED |
2020-10-02 |
BIA Separations–Univ Zagreb: purification technology, 202002– commercial license + collab developm of virus + viral vector immunoaffinity purification |
2020-02-19 |
Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH |
2024-11-21 |
Binding Site–Tecan: laboratory automation, 201906 collab existent developm automated solution for using MALDI-MS to diagnose blood cancers |
2019-06-06 |
Binding Site–Thermo Fisher: investment, 202210– acquisition £2.25b in cash from shareholder group led by Nordic Capital ANNOUNCED |
2022-10-31 |
Bio-Techne–Lunaphore: spatial omics, 202304– collab strategic partnership integrating COMET system with RNAscope technology |
2023-04-17 |
BioAnalytix–Zukunftsfonds Heilbronn: investment, 201904 merger acquisition of BioAnalytix Inc by Protagen Protein Services GmbH |
2019-04-10 |
BioClin Laboratories–Almac: investment, 201711 acquisition 100% of BioClin by Almac Group |
2017-11-01 |
Biocrates–MIG Founds: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure |
2019-09-01 |
Biocrates–NONE: investment, 201905– bankruptcy filed for subsidiary Metanomics Health GmbH |
2019-05-22 |
Biocrates–SEVERAL: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure |
2019-09-01 |
Biocrates–Xolaris Service KVG: investment, 201909c financing round incl MIG Fonds + GAF + Austria family office consolidation shareholder structure |
2019-09-01 |
Biodesix–MRM Proteomics: MALDI-TOF mass spectrometry, 201901– collab use of iMALDI technologies to advance blood-based lung cancer test |
2019-01-28 |
Biodesix–Oncimmune: clinical proteomic cancer test, 201906– collab excl commercialisation of EarlyCDT Lung in US by Biodesix |
2019-06-28 |
Biogenity–Denmark (govt): investment, 202203 Innovation Fund Denmark invests in Innobooster project BioSWITCH |
2022-03-23 |
Biognosys–Bruker: investment, 202301 acquisition €na of majority share in Biognosys by Bruker |
2023-01-04 |
Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology |
2021-08-27 |
Biognosys–SEVERAL: investment, 201908 financing round Series G from existing + new institutional + private investors |
2019-08-08 |
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED |
2021-07-26 |
Biotage–KKR: investment, 202302– investment $25m tog with sale of Astrea Bioseparations by Gamma for shares resulting in 17% share in Biotage of Gamma |
2023-02-15 |
BioTek Instruments–Agilent: investment, 201907–201908 acquisition $1.165b incl anticipated tax benefits net $1.05b |
2019-07-11 |
Biovectra–Agilent: investment, 202407– acquisition of Biovectra for $925m by Agilent from H.I.G. Capital |
2024-07-22 |
Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC |
2019-08-06 |
Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery |
2020-07-23 |
Bohui–Aviv Analytical: mass spectrometry software, 201806– supply TAMI molecular identifcation s/w now available for expression CMS |
2018-06-04 |
Brammer Bio–Thermo Fisher: investment, 201903– acquisition $1.7b in cash from Ampersand Capital Partners + Founders ANNOUNCED |
2019-03-24 |
Bruker–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems |
2019-06-03 |
Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems |
2020-01-06 |
Bruker–Bico: MS-based single cell proteomics, 202111– co-marketing of Cellenion’s cellenONE with timsTOF SCP mass spectrometers |
2021-11-15 |
Bruker–Genedata: bioinformatics, 201902 collab product integration Bruker new Ready-to-Run partner |
2019-02-05 |
Bruker–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data |
2019-05-31 |
Bruker–Murdoch Univ: analytical technologies, 201909– collab strategic alliance with ANPC incl MS + NMR for phenomics research |
2019-09-20 |
Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery |
2024-08-07 |
Bruker–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system |
2019-05-31 |
Bruker–Univ Nijmegen: mass spectrometry, 201904– collab establishment of joint Center of Excellence for Translational Omics at RUMC TML |
2019-04-16 |
Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab |
2020-08-07 |
BSSN Software–Merck (DE): investment, 201908 acquisition €na of BSSN Software GmbH by Merck KGaA |
2019-08-06 |
BugLab–Aber Instruments: investment, 202009–202102 acquisition €na of assets of BugLab LLC incl IP + trademarks |
2020-01-01 |
Bureau Veritas–Mérieux: investment, 202410– acquisition €360m of global food testing of Bureau Veritas by Mérieux NutriSciences |
2024-10-07 |
Bureau Veritas–SGS: investment, 202501– confirmed merger discussion |
2025-01-15 |
Cambridge Research & Instrumentation–Caliper: investment, 2010 acquisition of CRI by Caliper Life Sciences |
2010-01-01 |
Canopy Biosciences–Ampersand: investment, 201904 strategic growth investment from Ampersand Capital Partners |
2019-04-29 |
Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp |
2020-09-11 |
CatSci–Keensight Capital: investment, 202206 investment by Keensight Capital to support expansion |
2022-06-01 |
CatSci–Keensight Capital: investment, 202406 additional investment? by Keensight to support acquisition of Reach Separations by CatSci |
2024-06-25 |
CatSci–Reach Separations: chromatography, 202311– collab strategic allliance offering method development for small molecule development services |
2023-11-28 |